UPDATE: West Pharma (WST) Q1 EPS Tops Views; Reaffirms Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to UPDATE: West Pharma (WST) Q1 EPS Tops Views; Reaffirms Guidance

West Announces First-Quarter 2017 Results

April 27, 2017 7:00 AM EDT

EXTON, Pa., April 27, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017. 

First-Quarter 2017 Highlights

Reported net sales of $387.7 million grew 7.1% over the prior-year quarter. Net sales at constant currency grew by 8.7%. First-quarter 2017 reported-diluted EPS was $0.81, compared to prior-year quarter's results of reported-diluted EPS of $0.30 and adjusted-diluted EPS of $0.53. First-quarter 2017 reported-diluted EPS includes the impact of a tax benefit of $0.21 associated with the adoption of guidance... More